|
Antibodies in the treatment of aplastic anemia.
|
Feb 2012
|
Arch Immunol Ther Exp
|
aplastic anemia
|
|
Anemia as the Main Manifestation of Myelodysplastic Syndromes
|
Oct 2015
|
Semin Hematol
|
myelodysplastic syndromes (MDS)
|
|
Analysis of allogeneic hematopoietic stem cell transplantation with high-dose cyclophosphamide-induced immune tolerance for severe aplastic anemia
|
Oct 2016
|
Int J Hematol
|
aplastic anemia
|
|
An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes
|
Jul 2014
|
Leuk Res Rep
|
myelodysplastic syndromes (MDS)
|
|
An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes
|
Mar 2017
|
Am J Hematol
|
myelodysplastic syndromes (MDS)
|
|
An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS
|
Jun 2023
|
Blood Advances
|
myelodysplastic syndromes (MDS)
|
|
Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1
|
Mar 2017
|
Blood Advances
|
acute myeloid leukemia (AML)
|
|
Alternative donor transplants for severe aplastic anemia: current experience
|
Jan 2016
|
Semin Hematol
|
aplastic anemia
|
|
Alternative Donor Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Refractory Severe Aplastic Anemia
|
Dec 2016
|
Biol Blood Marrow Transplant
|
aplastic anemia
|
|
Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors
|
Feb 2021
|
Blood Advances
|
myelodysplastic syndromes (MDS)
|
